Early diagnosis and intensive treatment to maintain optimal glycaemic control reduce the morbidity and mortality associated with type 2 diabetes. To sustain glucose concentrations as near normal as possible — and make the Quality and Outcomes Framework diabetes targets achievable — generally requires use of more than one antidiabetic agent, which necessitates attention to licensing indications, as Dr Caroline Day explains.